BIOGENERICS

BioGenerics, Inc. operates as a biotechnology company. The company was incorporated in 2010 and is based in Redwood City, California.
BIOGENERICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2010-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.biogenerics.net
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.66 M USD
Technology used in webpage:
Apache
Current Employees Featured
Founder
Official Site Inspections
http://www.biogenerics.net
- Host name: sh23046.ispgateway.de
- IP address: 92.205.49.78
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin

More informations about "BioGenerics"
BioGenerics - Crunchbase Company Profile & Funding
BioGenerics, Inc. operates as a biotechnology company. The company was …See details»
Biogenerics - Overview, News & Similar companies | ZoomInfo.com
View Biogenerics (www.biogenerics.net) location in Hamburg, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
BioGenerics: Drug pipelines, Patents, Clinical trials - Synapse
Explore BioGenerics with its drug pipeline, therapeutic area, technology platform, 10 news.See details»
BIOGENERICS
Under Construction Biogenerics Pharma GmbH Eppendorfer Landstrasse 39 20249 Hamburg Tel. +49 (0) 40 4609 555-0 Fax: +49 (0) 40 4609 555-15 E-Mail: [email protected]See details»
BioGenerics - Products, Competitors, Financials, Employees ...
BioGenerics Frequently Asked Questions (FAQ) Where is BioGenerics's headquarters? BioGenerics's headquarters is located at 555 Bryant Street, Palo Alto. What is BioGenerics's …See details»
Biogenerics Pharma GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Biogenerics Pharma GmbH of Hamburg, Hamburg. Get the latest business insights from Dun & Bradstreet.See details»
BioGenerics - Financial Details - Crunchbase
BioGenerics is a biotechnology company based in Redwood City, California.See details»
Biogenerics Pharma GmbH - Drug pipelines, Patents, Clinical trials ...
Explore Biogenerics Pharma GmbH with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
BioGenerics - Contacts, Employees, Board Members, Advisors
BioGenerics is a biotechnology company based in Redwood City, California.See details»
Biogenerics standoff - PubMed
MeSH terms Biotechnology / organization & administration* Drug Approval / economics Drug Approval / organization & administration* Drug Industry / organization & administration* Drugs, …See details»
Our Purpose & Identity – BGP
BGP believes in the diverse contributions of employees and provides extra ordinary value to the customers, community, shareholders and other relevant …See details»
BioGenerics: 药物管线,专利,临床试验 - 智慧芽新药情报库
了解BioGenerics公司的药物管线,治疗领域,技术平台,以及它的15篇新闻。See details»
“What Is a Generic Biopharmaceutical? Biogeneric? Follow-On …
Biogenerics, like generic drugs, are just part of the business, and must be ratio-nally integrated, with appropriate information and information resources available for many user communities …See details»
Biogenerics FINAL - cagw.org
An accelerated pathway to bring biogenerics to the market that protects patients and balances the financial needs of brand name and generic drug companies, similar to Hatch-Waxman, is the …See details»
Science & Technology – BGP
BGP collaborates with leading global partners including the world health organization (WHO), medicines patent pool (MPP), institutions and industry partners to bring our developed …See details»
Biogeneric Drugs Market
Oct 9, 2024 The pricing competition between originator biologics and biogenerics significantly influences the biogeneric drugs market. Biologic medications, characterized by their large, …See details»
Biogenerics: potential benefits and obstacles - PubMed
Although the patents for several costly and successful biologics have expired or will expire in the near future, no biogenerics have yet been approved. The scientific difficulties of replicating …See details»
Biogeneric Drugs Market Size, Trends and Forecast To 2032
May 19, 2025 Unlike traditional generic drugs, biogenerics require extensive testing and demonstrate biosimilarity to reference biologics, which can be time-consuming and costly. The …See details»
Bioconductor - BiocGenerics
The Bioconductor project aims to develop and share open source software for precise and repeatable analysis of biological data. We foster an inclusive and collaborative community of …See details»
From Biologics to Biosimilars and Biobetters – Democratization of …
A biosimilar is a “biological product highly similar to the approved innovator product, with no clinically meaningful differences in safety, purity, and potency”. [1, 2, 3] Also known …See details»